Group 1 - The core viewpoint of the news is the performance and financial details of Sanbo Brain Science Hospital Management Group Co., Ltd, which saw a stock price increase of 5.12% to 80.28 CNY per share, with a trading volume of 601 million CNY and a market capitalization of 16.537 billion CNY [1] - The company, established on November 25, 2003, and listed on May 5, 2023, primarily provides medical services, with revenue composition as follows: 74.35% from medical services, 25.02% from pharmaceuticals, 0.39% from other sources, and 0.24% from supply chain [1] Group 2 - From the perspective of the top ten circulating shareholders, Huabao Fund's Huabao CSI Medical ETF (512170) reduced its holdings by 749,300 shares in the third quarter, now holding 4.0556 million shares, which accounts for 2.52% of the circulating shares [2] - The estimated floating profit from this reduction is approximately 15.8575 million CNY [2] - The Huabao CSI Medical ETF was established on May 20, 2019, with a current scale of 25.263 billion CNY, yielding 4.83% this year, ranking 3398 out of 5551 in its category, and 14.55% over the past year, ranking 3650 out of 4285 [2] Group 3 - The fund manager of Huabao CSI Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 109 days, managing total assets of 101.358 billion CNY [3] - During Hu Jie's tenure, the best fund return was 161.34%, while the worst was -98.01% [3]

基金经理郑英亮曾在海通证券从事证券研究分析工作。2017年11月加入华宝基金管理有限公司，担 任高级分析师。2021年12月31日起任基金经理。 | 基金募集申请获 | | | | | | --- | --- | --- | --- | --- | | 中国证监会核准 | | 证监许可【2025】2637 号文 | | | | 的文号 | | | | | | 基金募集期间 | | 从2026年1月5日至 2026年1月23日止 | | | | 验资机构名称 | | 容诚会计师事务所(特殊普通合伙) | | | | 募集资金划入基 金托管专户的日 | | 2026年1月27日 | | | | 期 | | | | | | 募集有效认购总 | | 61, 253 | | | | 户数(单位:户) | | | | | | 份额级别 | | 华宝优势产业混合 A | 华宝优势产业混合 C | 合计 | | 驻斯期间净认购 | | | | | | 金额(单位:人民 | | 4. 913, 565, 116. 16 | 860,683, 465, 95 | 5.774.248,582.11 | | 币元) | | | | ...

资料显示，深圳云天励飞技术股份有限公司位于广东省深圳市南山区粤海街道深圳湾科技生态园10栋B 座14-15楼、33楼,香港铜锣湾希慎道33号利园1期19楼1922室，成立日期2014年8月27日，上市日期2023 年4月4日，公司主营业务涉及人工智能算法、芯片技术,研发和销售面向应用场景的人工智能产品及解 决方案。主营业务收入构成为：消费级场景业务44.22%，行业级场景业务27.66%，企业级场景业务 27.10%，其他(补充)1.02%。 从基金十大重仓股角度 数据显示，华宝基金旗下1只基金重仓云天励飞。华宝上证科创板人工智能ETF（589520）四季度增持 6565股，持有股数24.3万股，占基金净值比例为3.51%，位居第十大重仓股。根据测算，今日浮盈赚取 约115.65万元。 华宝上证科创板人工智能ETF（589520）成立日期2025年3月5日，最新规模5.27亿。今年以来收益 18.06%，同类排名154/5548；成立以来收益39.51%。 华宝上证科创板人工智能ETF（589520）基金经理为丰晨成、曹旭辰。 1月27日，云天励飞涨5.67%，截至发稿，报88.72元/股，成交8.72亿元， ...

Group 1 - The core point of the article highlights that Fuda Alloy's stock price dropped by 5.08% to 27.46 CNY per share, with a trading volume of 233 million CNY and a turnover rate of 6.05%, resulting in a total market capitalization of 3.719 billion CNY [1] - Fuda Alloy Materials Co., Ltd. is located in Wenzhou Economic and Technological Development Zone, Zhejiang Province, and was established on April 5, 1999, with its listing date on May 17, 2018. The company's main business involves the research, production, and sales of electrical contact materials [1] - The revenue composition of Fuda Alloy's main business includes: contact materials 56.37%, composite contacts 22.28%, contact components 14.65%, others 6.39%, high-voltage direct current contacts 0.16%, and automation equipment 0.15% [1] Group 2 - From the perspective of major fund holdings, data shows that one fund under Huabao Fund has a significant position in Fuda Alloy. The Huabao Quantitative Stock Mixed Initiation A (017715) held 106,200 shares in the fourth quarter, accounting for 1.69% of the fund's net value, making it the second-largest holding [2] - The estimated floating loss for the Huabao Quantitative Stock Mixed Initiation A (017715) today is approximately 156,100 CNY. The fund was established on February 20, 2023, with a latest scale of 25.9009 million CNY, and has achieved a return of 9.75% this year, ranking 1914 out of 8861 in its category [2] - The fund manager Xu Linming has a cumulative tenure of 16 years and 125 days, with a total asset scale of 2.334 billion CNY, achieving a best fund return of 109.32% and a worst return of -43.03% during his tenure. Co-manager Yu Yinyou has a tenure of 3 years and 208 days, with a total asset scale of 475 million CNY, achieving a best return of 52.54% and a worst return of 15.94% during his tenure [2]

Group 1 - The core point of the news is that Nanwei Medical experienced a decline of 5.04% in its stock price, reaching 81.18 yuan per share, with a trading volume of 112 million yuan and a turnover rate of 0.72%, resulting in a total market capitalization of 15.249 billion yuan [1] - Nanwei Medical Technology Co., Ltd. is located in Jiangbei New District, Nanjing, Jiangsu Province, and was established on May 10, 2000, with its listing date on July 22, 2019. The company's main business involves the research, development, manufacturing, and sales of minimally invasive medical devices [1] - The revenue composition of Nanwei Medical is as follows: endoscopic consumables account for 77.80%, other categories 13.17%, tumor intervention 7.28%, visualization 1.00%, and other (supplementary) 0.74% [1] Group 2 - From the perspective of the top ten circulating shareholders of Nanwei Medical, Huabao Fund has one fund among them. The Huabao CSI Medical ETF (512170) reduced its holdings by 459,000 shares in the third quarter, holding a total of 3.2232 million shares, which represents 1.72% of the circulating shares. The estimated floating loss today is approximately 13.8921 million yuan [2] - The Huabao CSI Medical ETF (512170) was established on May 20, 2019, with a latest scale of 25.263 billion yuan. Year-to-date returns are 9.07%, ranking 2041 out of 5579 in its category; the one-year return is 19.46%, ranking 3487 out of 4270; and since inception, the return is 11.04% [2]

该基金属于偏股混合型基金。截至1月22日，单位净值为1.435元。基金经理是唐雪倩，目前管理6只基金。其中，截至1月22日，华宝新价值混合近一年复权 单位净值增长率最高，达22.06%；华宝安享混合A最低，为4.23%。 基金管理人在四季报中表示，华宝红利精选基金定位为价值策略产品，对于估值匹配度和盈利确定性的要求相对较为明确。基金定位于在全市场具备较高股 息率和分红可持续性，且经营质地优质、现金流表现良好的公司中优选股票组合，维持风格的连贯和清晰。报告期内基金保持了相对风格指数的超额收益， 整体波动延续正常水平。 客观而言，从中长期的角度，红利类的资产为市场特别是偏长期资产配置的投资者提供了长周期的配置选择，基金将在长期中继续恪守投资边际，做好相应 的股票选择和策略管理。 截至1月22日，华宝红利精选混合A近三个月复权单位净值增长率为4.04%，位于同类可比基金498/621；近半年复权单位净值增长率为7.50%，位于同类可比 基金545/621；近一年复权单位净值增长率为20.40%，位于同类可比基金522/613；近三年复权单位净值增长率为38.30%，位于同类可比基金117/535。 AI基金华宝红利 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及董事保证基金季度报告所载资料不存在虚假记载、误导性陈述或重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 华宝基金管理有限公司旗下： 1.华宝宝康消费品证券投资基金 2.华宝宝康灵活配置证券投资基金 3.华宝宝康债券投资基金 4.华宝多策略增长开放式证券投资基金 5.华宝现金宝货币市场基金 6.华宝动力组合混合型证券投资基金 14.华宝增强收益债券型证券投资基金 15.上证180价值交易型开放式指数证券投资基金 16.华宝上证180价值交易型开放式指数证券投资基金联接基金 17.华宝新兴产业混合型证券投资基金 7.华宝收益增长混合型证券投资基金 8.华宝先进成长混合型证券投资基金 9.华宝行业精选混合型证券投资基金 10.华宝中证100交易型开放式指数证券投资基金联接基金 11.华宝中证100交易型开放式指数证券投资基金 12.华宝海外中国成长混合型证券投资基金 13.华宝大盘精选混合型证券投资基金 18.华宝可转债债券型证券投资基金 19.华宝标普石油天然气上游股票指数证券投资基金（LOF） 20.华宝医药生物优选混合型证券投 ...

写在文章前的声明：在本文之前的说明：本文中所列的投资信息，只是一个对基金资产净值进行排行的客观描述，并无主观倾向性，也不是投资建议，纯属 娱乐性质。 | 基金简称 PK | | | 最新净法 | | --- | --- | --- | --- | | 1 | 东方阿尔法 ... C | 1.0491 | -3.81% | | | 018363 | 2026-1-21 | | | 2 | 东方阿尔法 ... A | 1.0602 | -3.80% | | | 018362 | 2026-1-21 | | | 3 | 东财景气驱 ... C | 1.6390 | -3.47% | | | 019144 | 2026-1-21 | | | 4 | 东财景气驱...A | 1.6593 | -3.47% | | | 019143 | 2026-1-21 | | | 5 | 前海开源沪…业 | 1.6652 | -3.16% | | | 004321 | 2026-1-21 | | | 6 | 华宝海外新 ... C | 1.6141 | -3.09% | | | 017145 | 2026-1-20 | | | 7 ...

Group 1 - The core viewpoint of the news is that Tongce Medical's stock has seen a significant increase of 5.19%, reaching a price of 46.60 yuan per share, with a trading volume of 570 million yuan and a turnover rate of 2.80%, resulting in a total market capitalization of 20.844 billion yuan [1] - Tongce Medical Co., Ltd. is located in Hangzhou, established on August 30, 1995, and listed on October 30, 1996. The company's main business involves medical service investment and dental medical services [1] - The revenue composition of Tongce Medical is as follows: medical services account for 92.84%, product sales 4.06%, construction engineering 2.72%, and others 0.38% [1] Group 2 - From the perspective of the top ten circulating shareholders of Tongce Medical, Huabao Fund's ETF, Huabao Zhongzheng Medical ETF (512170), reduced its holdings by 1.5804 million shares in the third quarter, now holding 8.8854 million shares, which represents 1.99% of the circulating shares [2] - The Huabao Zhongzheng Medical ETF (512170) was established on May 20, 2019, with a latest scale of 26.404 billion yuan. Year-to-date returns are 7.98%, ranking 1481 out of 5542 in its category; the one-year return is 16.76%, ranking 3551 out of 4243; and since inception, the return is 9.93% [2] - The fund manager of Huabao Zhongzheng Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 101 days, with total fund assets of 100.204 billion yuan. The best fund return during his tenure is 165.65%, while the worst is -98.01% [2]

Group 1 - The core point of the article highlights that Puyuan Information's stock increased by 5.06% to 35.09 CNY per share, with a trading volume of 1.20 billion CNY and a turnover rate of 3.84%, resulting in a total market capitalization of 3.274 billion CNY [1] - Puyuan Information Technology Co., Ltd. is located in the China (Shanghai) Free Trade Pilot Zone and was established on March 26, 2003, with its listing date on December 4, 2019. The company primarily provides software infrastructure platforms and application software development services to large and medium-sized users in various industries, including finance, government, energy, telecommunications, and manufacturing [1] - The company's revenue composition indicates that 84.68% comes from software infrastructure platform business, while 15.32% is from application development based on the software infrastructure platform [1] Group 2 - From the perspective of Puyuan Information's top ten circulating shareholders, Huabao Fund's Huabao CSI Financial Technology Theme ETF (159851) entered the top ten shareholders in the third quarter, holding 1.2853 million shares, which accounts for 1.38% of the circulating shares. The estimated floating profit today is approximately 2.1722 million CNY [2] - The Huabao CSI Financial Technology Theme ETF (159851) was established on March 4, 2021, with a latest scale of 12.319 billion CNY. Year-to-date returns are 4.31%, ranking 2828 out of 5542 in its category; the one-year return is 27.58%, ranking 2707 out of 4243; and since inception, the return is 76.52% [2] Group 3 - The fund managers of Huabao CSI Financial Technology Theme ETF are Chen Jianhua and Cao Xucheng. As of the report, Chen Jianhua has a cumulative tenure of 13 years and 34 days, with a total fund asset scale of 27.702 billion CNY, achieving a best fund return of 186.34% and a worst return of -49.65% during his tenure [3] - Cao Xucheng has a cumulative tenure of 245 days, with a total fund asset scale of 35.182 billion CNY, achieving a best fund return of 132.7% and a worst return of -2.42% during his tenure [3]